The DRAGON MEDIC team sees winning the Maj. Gen. Greene Innovation Award as a recognition of the value of their novel approach to rapidly fielding a vitally needed capability, as well as of the team’s hard work getting the project to the point where it is ready to hand off to the 1st AML.

“I have been working on the underlying technology for this pilot for all 10 years that I have been here,” says Developmental Diagnostics Branch Chief Dr. Christopher Stefan. “In those 10 years, technology has progressed exponentially. What used to take two days now takes two hours. To be able to not only conceptualize something but then to turn it into a product and deliver it to the people who can use it for the intended purpose is very rewarding.”

“It’s nice to see the things we’ve made getting out to play more of a functional and operational role,” agrees Koehler. “It’s good the work that we’ve done on this project come to fruition. It’s going to make a real difference.”

Content Original Link:

https://www.army.mil/article/273793/portable_pathogen_detector_nabs_acquisition_innovation_award_for_usamriid

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.